News and Announcements
Climate Tech Heats Up With $400M Invested In Early-stage Companies in Australia
- Published December 14, 2022 8:06AM UTC
- Publisher Osama Hassan
- Categories Capital Raising Tips
Here is a copy of the 2022 ANZ Climate Tech Industry Report!
This report contains industry insights and data around the climate tech, circular economy, and renewables market in Australia and New Zealand.
On a personal note, this vertical really excites me because, beyond the innovation and economics, it’s great for the environment too.
Mick Liubinskas has summarised some key stats:
– nearly 1,000 gigatonnes of CO2e removal/reduction ambition in total
– they have raised $1.4 billion to date with $700m from international investors
– over 4,000 jobs created, 2,000 more to be hired in the next 12 months
– 39.7% of climate tech companies have a female founder
On the capital raising front, according to Brer Adams, interest in climate technologies has exploded in recent years, with deal activity in early-stage venture companies reaching USD400 million in 2021 in Australia, according to Pitchbook data, 10 times’ the rate of the prior year. This is huge!
Over 85% of the latest funding rounds were at the pre-seed and seed stages across these verticals: agrifood, biosphere, built environment, carbon markets, circular economy, data and finance, mobility, renewables, resources, and storage.
Of these, Agri Food companies are aiming to raise the most capital, reflecting the large domestic industries and strong focus of community groups and investors.
Highly recommend checking this out.
On a closing note, it was great to see some familiar names in the report too. Great work to everyone doing excellent work in this industry.
Click here to view the original Linkedin post.
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
